Kymera Therapeutics, Inc. (KYMR) shares rallied 7.8% in the last trading session to close at 40.12.Thismovecanbeattributabletonotablevolumewithahighernumberofsharesbeingtradedthaninatypicalsession.Thiscomparestothestock′s13.640.12. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 13.6% loss over the past four weeks.Shares gained as investors were impressed by the pipeline updates provided by the company at the J.P. Morgan Annual Healthcare Conference. Kymera has a sound cash position and ended 2024 with an estimated cash of 40.12.Thismovecanbeattributabletonotablevolumewithahighernumberofsharesbeingtradedthaninatypicalsession.Thiscomparestothestock′s13.6850 million, ...
Kymera Therapeutics(KYMR) ZACKS·2025-01-15 15:41